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Normal aging in humans and rodents is accompanied by a progressive increase in adiposity. To investigate the role of
hypothalamic neuronal circuits in this process, we used a Cre-lox strategy to create mice with specific and progressive
degeneration of hypothalamic neurons that express agouti-related protein (Agrp) or proopiomelanocortin (Pomc),
neuropeptides that promote positive or negative energy balance, respectively, through their opposing effects on
melanocortin receptor signaling. In previous studies, Pomc mutant mice became obese, but Agrp mutant mice were
surprisingly normal, suggesting potential compensation by neuronal circuits or genetic redundancy. Here we find that
Pomc-ablation mice develop obesity similar to that described for Pomc knockout mice, but also exhibit defects in
compensatory hyperphagia similar to what occurs during normal aging. Agrp-ablation female mice exhibit reduced
adiposity with normal compensatory hyperphagia, while animals ablated for both Pomc and Agrp neurons exhibit an
additive interaction phenotype. These findings provide new insight into the roles of hypothalamic neurons in energy
balance regulation, and provide a model for understanding defects in human energy balance associated with
neurodegeneration and aging.
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Introduction
The mechanisms by which warm-blooded animals balance
energy intake with energy expenditure have come under
increasing scrutiny in recent years. Important components of
this process are the changes associated with aging. In humans,
rats, and mice, young adults exhibit a remarkable ability to
regulate fuel stores so that the net change in adiposity over
long periods of time is a small fraction of energy consumed.
As part of the normal aging process, however, a slow but
progressive increase in adiposity occurs throughout most of
adulthood (reviewed in [1,2]). In both humans and rodents,
these changes occur independently of environmental varia-
tion, and are likely to be caused by the progressive impair-
ment of mechanisms that normally control energy
homeostasis [3–5].
Studies in rodents suggest the underlying causes of age-
related changes in energy homeostasis are likely to involve the
central melanocortin system [5–7], in which two subgroups of
neurons in the arcuate nucleus of the hypothalamus, those
marked by the expression of proopiomelanocortin (Pomc) or
agouti-related protein (Agrp), sense total body adiposity by
sampling circulating indicators such as leptin and insulin.
Pomc and Agrp neurons integrate and relay this information
to downstream central nervous system effectors that act to
balance energy stores via changes in both energy intake and
expenditure, with activation of Pomc neurons promoting
negative energy balance, and activation of Agrp neurons
promoting positive energy balance [8,9].
To some extent, experimental mouse genetic manipulations
support this view: deletion of the Pomc gene [10] or transgenic
overexpression of Agrp [11] causes hyperphagia and obesity.
The results of knockout experiments, however, have been
more difﬁcult to interpret. Agrp-deﬁcient mice have been
reported to have no detectable defects in energy balance [12],
although treatment of adult mice with RNAi against Agrp
causes a transient decrease in energy expenditure [13].
An important consideration in interpreting the results of
these experiments is the relationship between the action of
Pomc or Agrp and that of the Pomc- or Agrp-expressing
neurons. The view of energy homeostasis as a system based on
neuronal subtypes rather than neuropeptides per se derives
in part from the observations that Pomc and Agrp are each
coexpressed with other neuropeptides that have similar
effects, Cart and neuropeptide Y (Npy), respectively [8], and
in part from the observations that the different neuronal
subtypes exhibit reciprocal patterns of electrical and/or
signaling activity [14,15]. From this perspective, perturbing
Pomc or Agrp gene expression may not fully reveal the
function of the Pomc or Agrp neuron, respectively.
To better understand the role of Pomc and Agrp neurons
in energy balance, and to model how altered activity of these
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neurons might account for age-related changes in adiposity,
we constructed animals in which Pomc- or Agrp-expressing
cells were progressively ablated by deleting the mitochondrial
transcription factor A (Tfam) gene using a Cre-lox strategy.
Tfam activity is required for mitochondrial genome tran-
scription and replication, and Tfam-deﬁcient cells exhibit
progressive loss of cellular respiration and eventual cell death
[16,17]. Here we report that animals in which the Tfam gene is
removed from Pomc- or Agrp-expressing cells exhibit adult-
onset defects in energy balance that provide insight into the
normal role of speciﬁc hypothalamic neuronal subtypes. Our
ﬁndings demonstrate that central nervous system regulation
of body weight by Agrp neurons involves compensation by
redundant genes, and provide a model for understanding
defects in energy balance associated with aging and neuro-
degeneration.
Results
Construction and Characterization of Pomc- and Agrp-
Neuronal Ablation Animals
In previous experiments using a Cre recombinase trans-
gene controlled by Pomc or Agrp regulatory elements, we
demonstrated that expression of the transgene was speciﬁc
for the different neuronal subtypes in adult animals [9]. To
further characterize the timing and pattern of transgene
expression, we examined different tissues from mice carrying
the PomcCre or AgrpCre transgene together with the lacZ
reporter allele Gt(Rosa)26Sortm1Sor (R26R) [18].
In the arcuate nucleus of the hypothalamus, activation of
R26R by the PomcCre transgene became apparent by
embryonic day 17.5; activation of R26R by the AgrpCre
transgene, however, was not detectable until 2–3 wk of age
(Figure 1). These results correspond to what has been
described previously for normal development of the melano-
cortinergic system, with the hypothalamic Pomc system
becoming established during fetal brain development, but
the Agrp system developing after birth [19,20]. Activation of
R26R by the PomcCre transgene also occurs in the nucleus
tract solitarius of the hindbrain, and the anterior and
intermediate lobe of the pituitary in neonatal animals
(unpublished data), which are areas in which Pomc is normally
expressed. The early onset of Pomc expression in the arcuate
nucleus suggests that the Pomc neurons may play a role in the
development of the hypothalamus. Expression of Pomc has
Figure 1. Pattern of R26R Activation in Mice Carrying the PomcCre or
AgrpCre Transgene
Whole brains from Tg.PomcCre/þ; R26R/þ or Tg.AgrCre/þ; R26R/þmice of
the indicated age were fixed and stained with Xgal as described in [9].
Photographs show the ventral brain surface, and coronal sections (not
shown) indicate that Xgal-stained neurons lie in the arcuate nucleus of
the hypothalamus. As assessed by the extent of Xgal staining, Cre-
induced recombination in Pomc neurons is complete by embryonic day
17.5; however, Cre-induced recombination in Agrp neurons is just
beginning at 2 wk of age (arrows) and is not complete until 3–4 wk of age.
DOI: 10.1371/journal.pbio.0030415.g001
Figure 2. Immunostaining of a-MSH or Agrp in Control and Tfam Mutant
Animals of Different Ages
Hypothalami from control (Tfam flox/þ; Tg.PomcCre/þor Tfam flox/flox;þ/þ),
Pomc-specific Tfam mutant (Tfam flox/flox; Tg.PomcCre/þ), and Agrp-
specific Tfam mutant (Tfam flox/flox; Tg.AgrpCre/þ) animals were harvested
at the indicated ages and immunostained for a-MSH or Agrp as indicated.
IR, immmunoreactivity.
DOI: 10.1371/journal.pbio.0030415.g002
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also been reported in the skin, but we did not detect activation
of the R26R transgene outside the brain or pituitary gland.
The loxP-ﬂanked Tfam allele, Tfamﬂox, was originally con-
structed by Larsson and colleagues [16] and has been used for
a number of cell type–speciﬁc ablation studies [17,21,22].
Animals with global Tfam deﬁciency die in early embryo-
genesis, but animals with Tfam deﬁciency in the neocortex are
normal until 5–6 mo of age, when animals die suddenly with
massive neuronal cell death. In these latter studies, Cre
recombinase was driven by regulatory elements from the
calcium/calmodulin-dependent protein kinase II alpha gene
(Camk2a), which is maximally expressed at 1 mo of age, and the
4- to 5-mo delay between Tfam deﬁciency and neuronal cell
death is thought to be due to the gradual depletion of
mitochondrial gene products from postmitotic cells [17].
Thus, we anticipated that ablation of Pomc or Agrp neurons
due to loss of Tfam would be complete by 6 mo of age.
We intercrossed Tfam ﬂox/ﬂox and Tg.PomcCre/þ; R26R/þ or
Tg.AgrpCre/þ; R26R/þ animals, and identiﬁed groups of F2
animals as mutant ablation (Tfam ﬂox/ﬂox; Tg.Cre/?), Tfam
control (Tfam ﬂox/þ; Tg.Cre/?), or Cre recombinase control
(Tfam ﬂox/ﬂox;þ/þ). Consistent with our earlier characterization
of the PomcCre and AgrpCre transgenic lines, we observed
no phenotypic differences in the different types of control
animals; in the studies described below, results for Tfam
control and Cre recombinase control animals are pooled. We
also generated animals deﬁcient for both Pomc and Agrp
cells (Tfam ﬂox/ﬂox; Tg.PomcCre/þ; Tg.AgrpCre/þ), referred to below
as ‘‘double-ablation’’ mice.
We examined the pattern and extent of immmunohisto-
chemical staining for a–melanocyte-stimulating hormone (a-
MSH) and Agrp in Tfam mutant and control mice at multiple
time points. At 2 and 4 mo of age, a-MSH and Agrp neurons in
Tfam mutant mice appeared no different from control mice
(Figure 2). However, at 7 mo of age, we found that in Pomc-
speciﬁc Tfammutant mice, immunohistochemical staining for
a-MSH was dramatically reduced compared to control
animals, but immunohistochemical staining for Agrp was
unaffected (Figure 3). Similarly, in Agrp-speciﬁc Tfam mutant
mice, immunohistochemical staining for Agrp was dramati-
cally reduced compared to control animals, but immunohis-
tochemical staining for a-MSH was unaffected (Figure 3). In
both cases, there was no detectable gliosis or effect on brain
architecture, indicating that the ablation was highly speciﬁc.
As an additional measure of ablation, we examined Xgal
staining of hypothalamic sections from experimental and
control mice that carried the R26R reporter gene, since, for
example, loss of Agrp neurons from Tg.AgrpCre/þ; Tfam ﬂox/ﬂox ;
R26R/þ mice should be reﬂected in a reduced number of
Xgal-positive neurons. For both Pomc-speciﬁc and Agrp-
speciﬁc Tfam mutant mice, very few Xgal-positive cells were
detectable; furthermore, mRNA in situ hybridization revealed
a dramatic reduction in the number of Agrp-expressing cells
(Figure 4). Thus, loss of Tfam induced by a PomcCre or
Figure 3. Effect of Pomc-Specific Tfam Deficiency on Pomc and Agrp Immunostaining
Each column of panels shows coronal sections from a 7-mo-old control (Tfam flox/þ; Tg.PomcCre/þor Tfam flox/flox;þ/þ), Pomc-specific Tfam mutant (Tfam
flox/flox; Tg.PomcCre/þ), and Agrp-specific Tfam mutant (Tfam flox/flox; Tg.AgrpCre/þ) on the left, middle, and right, respectively. Each section was stained
for a-MSH or Agrp as indicated. The three lower panels show coronal sections stained to reveal cell nuclei (DAPI) and immunostained for GFAP, and
indicate that ablation of Pomc or Agrp neurons does not grossly disturb tissue architecture, cell number, or stimulate astrocytosis. The sections shown
are representative of three different animals that were examined.
IR, immmunoreactivity.
DOI: 10.1371/journal.pbio.0030415.g003
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AgrpCre transgene gives rise to postnatal loss of Pomc or
Agrp neurons that is speciﬁc and extensive.
Effects of Pomc and/or Agrp Ablation on Energy Balance
and Neuroendocrine Axis
Pomc-ablation mice exhibited a progressive adult-onset
obesity in which increased weight gain compared to controls
was ﬁrst detectable at 4 mo of age, and the magnitude of the
effect was greater in females (;30% increase in body weight)
than in males (;15% increase in body weight) (Figure 5A and
5B). Agrp-ablation mice exhibited little difference in body
weight compared to control animals, although at every time
point, the mean body weight for mutant animals was slightly
less than control animals for both males (Figure 5C) and
females (Figure 5D). A more signiﬁcant role for Agrp neurons
in total body weight was uncovered by examining double-
ablation mice; animals deﬁcient for both neuronal subtypes
weigh more than control animals but less than Pomc single-
ablationmice in bothmales (Figure 5E) and females (Figure 5F).
Using dual energy X-ray absorptiometry (DEXA) or MRI to
measure adipose versus nonadipose tissue, we observed that
in 7- to 10-mo-old animals, loss of Pomc-expressing cells
caused an increase in both compartments, with a relative
effect that was slightly greater on fat than on lean body mass
(Figure 6A and 6B). Agrp ablation caused a small but
signiﬁcant decrease of fat mass in females but not in males
(Figure 6D). We also measured rates of food intake and energy
expenditure in Pomc-ablation animals, and observed an effect
on both components of the energy balance equation. Pomc-
ablation mice consumed approximately 10% more than
control animals, and exhibited rates of O2 consumption
approximately 10% less than control animals (Figure 7).
The Pomc-ablation mice lost Pomc-expressing pituitary
cells in addition to Pomc neurons, and therefore had chronic
ACTH insufﬁciency with reduced basal corticosterone levels
(unpublished data). Although both Pomc knockout and the
Pomc-ablation mice showed corticosterone deﬁciency due to
lack of ACTH, the Pomc-ablation mice developed adrenal
glands (unpublished data), whereas adrenal glands in the
Pomc knockout mice were largely absent [10]. We used long-
term corticosterone replacement to investigate whether or
not hypoadrenalism contributed to abnormal energy balance
in Pomc-ablation mice. Corticosterone pellets (10 mg; 21 d)
were implanted into both Pomc-ablation and control mice,
and measurements of food intake and energy expenditure
were made after 10–12 d. In control animals, corticosterone
replacement had no effect on energy expenditure (Figure 7C
and 7D) or food intake (Figure 7E). In Pomc-ablation animals,
corticosterone replacement had no effect on energy expen-
diture (Figure 7C and 7D) but stimulated food intake by
approximately 20% over a level that was already elevated
relative to control (Figure 7E). These observations suggest
Figure 4. Expression of the R26R Cre Reporter Gene in Pomc- or Agrp-
Specific Tfam Mutant Animals
Animals carrying the PomcCre or AgrpCre transgene together with the
lacZ reporter allele for Cre recombination Gt(Rosa)26Sortm1Sor (R26R)
were intercrossed with Tfam flox/flox animals. F2 progeny of the
indicated genotype were sacrificed at 7 mo of age, and hypothalamic
coronal sections stained for Xgal. In this situation, Xgal staining serves
as an autonomous histologic marker, and loss of Xgal staining in Tfam
mutant animals is therefore secondary to cell death. Sections are
representative of three to four per genotype group that were
examined. The panel on the lower right shows the number of Agrp-
expressing neurons in the control and Agrp-Tfam mutants as
determined by fluorescence in situ hybridization to Agrp mRNA.
**, p  0.01. Error bars¼ standard error of the mean.
DOI: 10.1371/journal.pbio.0030415.g004
Figure 5. Effect of Pomc- and/or Agrp-Specific Tfam Mutations on Body
Weight
(A–D) show longitudinal measurements of body weight in animals of the
indicated genotype and sex. (E) and (F) show comparisons of single
(Pomc-specific) and double (Pomc- and Agrp-specific) Tfam deficiency
for 6- and 9-mo-old animals.
*, p  0.05; **, p  0.01. Error bars ¼ standard error of the mean.
DOI: 10.1371/journal.pbio.0030415.g005
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that ablation of Pomc neurons is sufﬁcient to reduce energy
expenditure and increase food intake; in fact, concomitant
adrenocortical deﬁciency in Pomc-ablation mice would, if
anything, mitigate the obesity phenotype.
a-MSH is also thought to stimulate the thyroid axis via
thyroid-releasing hormone, but measurements of total T4 in
Pomc-ablation mice were not signiﬁcantly different from
those of control mice (Figure 7F).
Impaired Compensatory Refeeding in Pomc-Ablation Mice
Because Pomc neurons serve as primary hypothalamic
sensors for adiposity signals, we suspected that hyperphagia
and reduced energy expenditure in Pomc-ablation mice were
caused by an underlying abnormality in the hypothalamic
circuitry that normally maintains peripheral energy stores.
To test this idea directly, we examined the ability of 6-mo-old
mutant and control animals to increase food intake acutely
following a period of food deprivation. After a 48-h fast,
animals normally compensate with a transient hyperphagia
sufﬁcient to restore adipose depots to prefasting levels, a
phenomenon typically associated with a 2-fold increase in
food intake over 24 h. We found that Pomc-ablation mice
exhibit an impaired compensatory refeeding response,
consuming approximately 25% less than expected (Figure
8A); conversely, Agrp-ablation mice exhibited a normal
refeeding response (Figure 8B). These effects also were
apparent in weight gain after refeeding; control and Agrp-
ablation mice were able to recover their body weight
precisely within 24 h after fasting, while Pomc-ablation mice
were not (Figure 8C and 8D).
To investigate the extent to which adrenocortical impair-
ment might contribute to the refeeding abnormality in Pomc-
ablation mice, we carried out the experiment before and after
implanting corticosterone replacement pellets. Although this
approach cannot completely mimic the normal circadian and
metabolic ﬂuctuations of glucocorticoids, we found that
during the period of corticosterone replacement, blood
corticosterone levels were increased after fasting in both
controls and mutants (unpublished data), indicating that the
adrenal glands of the Pomc-ablation mice were able to mount
a stress response. Even though corticosterone replacement
stimulated food intake (Figure 7E) and weight gain (unpub-
lished data), mutant mice were (Figure 8E) unable to
compensate for body weight lost by fasting.
Agrp and Npy mRNA levels are normally upregulated by
fasting, and have been suggested to contribute to compensa-
tory refeeding. Surprisingly, we found that Pomc-ablation
mice exhibited a normal response to fasting in terms of their
ability to upregulate Agrp and Npy mRNA (Figure 8F). These
ﬁndings suggest that impaired compensatory refeeding in
Pomc-ablation mice is caused not by inability to upregulate
orexigenic neuropeptides, but instead by the absence of
Pomc neurons. Thus, Pomc-ablation mice represent an
interesting paradox in which mutant animals are hyperphagic
at baseline, yet are unable to increase their food intake to
compensate for food deprivation.
Discussion
Although physical or chemical lesioning studies carried out
60 years ago ﬁrst drew attention to the ventromedial area and
the lateral hypothalamic area of the hypothalamus as sites
important for regulating energy balance [23,24], functional
heterogeneity within the arcuate nucleus of the hypothal-
amus was not recognized until recently. Our results address
functional heterogeneity in a speciﬁc way by ablating
subpopulations of neurons with a Cre-lox strategy. Distin-
guishing between the action of a neuropeptide and the action
of a neuropeptide-speciﬁc cell is also apparent by considering
previous studies of Agrp and Pomc knockout mice. In contrast
to Agrp knockout or Agrp; Npy double-knockout mice, which
are normal [12], Agrp-ablation mice show reduced adiposity.
This reduction in adiposity is most apparent in the Agrp;
Pomc double-ablation mice, an observation that is reminis-
cent of what was previously described for the interaction of
Npy and Lepob [25]. This observation points to an important
role for other neuropeptides and neurotransmitters besides
Agrp and Npy. One such candidate is gamma-aminobutyric
acid, which has been shown to be released from Npy neurons
and inhibit the activity of Pomc neurons [14]. The relatively
mild weight phenotype of the Agrp-ablation mice could be
due to a small fraction of the Agrp neurons that escape
ablation, differences in genetic background, potential com-
pensation developed during the course of progressive cell
loss, or a combination of these mechanisms. One such
potential compensatory mechanism is neuronal plasticity
and rewiring of the feeding circuits as described by Horvath
and colleagues [26].
Nonetheless, our ﬁndings and similar results recently
published by Bewick et al. [27], Gropp et al. [28], and Luquet
et al. [29] demonstrate that ablation of Agrp neurons yields a
phenotype that is more dramatic than a knockout of Agrp (or
Figure 6. Lean Body Composition of Animals with Pomc- or Agrp-
Specific Tfam Deficiency
Lean body mass of animals of the indicated genotype was determined as
described in Materials and Methods. For Pomc-specific Tfam mutant
animals (A), numbers of animals were: control n ¼ 10, mutant n ¼ 4
(male); and control n¼ 6, mutant n¼ 4 (female). For Agrp-specific Tfam
mutant animals (C), numbers of animals were control n¼ 4, mutant n¼ 4
(male); and control n ¼ 6, mutant n ¼ 8 (female). (B) and (D) show
comparisons of control and mutant animals of the indicated genotype
and sex for fat masses of 7- to 10-mo-old animals. For Pomc-specific
Tfam mutant animals (B), numbers of animals were control n ¼ 10,
mutant n¼ 4 (male); and control n¼ 6, mutant n¼ 4 (female). For Agrp-
specific Tfam mutant animals (D), numbers of animals were control n¼4,
mutant n¼ 4 (male); and control n¼ 6, mutant n ¼ 8 (female).
*, p  0.05; **, p  0.01. Error bars¼ standard error of the mean.
DOI: 10.1371/journal.pbio.0030415.g006
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combined ablation of Agrp and Npy [12]). Furthermore, acute
ablation of the Agrp neurons over a time frame of days
[28,29] yields a more severe phenotype than progressive
ablation of the Agrp neurons over a time frame of months
due to neurodegeneration conferred by Tfam deﬁciency.
These observations highlight the potential for neuronal
plasticity and developmental compensation [26], and have
implications for both experimental strategies and therapeutic
approaches to energy homeostasis. By contrast, Pomc knock-
out mice [10,30,31] exhibit a phenotype that is more dramatic
than ablation of Pomc neurons, with obesity starting at 4–8
wk of age and an eventual ;50% increase in body weight,
whereas Pomc-ablation mice develop obesity starting at 4 mo
of age with an eventual 15%–30% increase in body weight
(Figure 5). The later time of onset can be attributed simply to
the difference between germline inheritance of a knockout
allele and somatic loss of mitochondrial function in speciﬁc
cells, but several factors could account for the difference in
magnitude, including an inbred versus a mixed genetic
background, a small fraction of Pomc neurons that escape
ablation, or additional products released by Pomc neurons
that counter the effects of Pomc.
The surprising result that the Pomc-ablation mice failed to
defend their body weight normally after food deprivation is
somewhat paradoxical given their chronic hyperphagia and
obesity. We propose that normal compensatory refeeding
Figure 7. Food Intake and Energy Expenditure in Animals with Pomc- or Agrp-Specific Tfam Deficiency
(A and B) Daily food intake was measured for 7 d as described in Materials and Methods. For (A), numbers of animals used (control and Pomc-Tfam
mutant) were 6-mo-old male (n¼ 13, n¼ 7); 6-mo-old female (n¼ 10, n¼ 6); . 8-mo-old male (n¼ 10, n¼ 6); and . 8-mo-old female (n¼ 13, n¼ 6).
(C, D) O2 consumption was measured over a 24-h period as described in Materials and Methods; panels illustrate results from a single control and a
single Pomc-Tfam mutant animal before and after (10–12 d) corticosterone replacement; these results are representative of four control and four
mutant animals that were examined.
(E) Daily food intake was significantly increased after corticosterone replacement in Pomc-Tfam mutant animals (n¼6) but not in control (n¼9) animals.
(F) Measurement of total serum T4 levels in control (n¼ 7) and Pomc-Tfam mutant (n ¼ 5) animals.
*, p  0.05; **, p  0.01. Error bars¼ standard error of the mean.
DOI: 10.1371/journal.pbio.0030415.g007
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requires either downregulation of Pomc neuronal activity,
decreased Pomc release, or both, and that normal down-
regulation is abolished in Pomc-ablation mice. This sugges-
tion is consistent with the observation that widespread
transgenic overexpression of Pomc also gives rise to impaired
compensatory refeeding thought to be due to disruptions of
Pomc regulation; however, these animals exhibit a chronic
state of negative rather than positive energy balance [32].
Electrophysiologic studies have suggested a melanocorti-
nergic neuronal circuit in which Agrp neurons control the
activity of Pomc neurons [14,33], but the reciprocal ques-
tion—do Pomc neurons control the activity of Agrp
neurons—has not been addressed. However, Agrp and Npy
mRNA levels responded normally to food deprivation in our
Pomc-ablation mice, which indicates that a potential pathway
from Pomc neurons to Agrp neurons, should one exist, does
not act by controlling production of Agrp or Npy.
Our strategy for genetic ablation of Pomc and Agrp
neurons is based on a prior study in which Cre-mediated
loss of Tfam driven by the Camk2a promoter caused wide-
spread neuronal cell death due to loss of mitochondrial ATP
production [17]. In some ways, this approach is similar to that
used by Sakurai and colleagues [34] for the ablation of
hypocretin/orexin (Hcrt)-expressing neurons, in which trans-
genic expression of a polyglutamine-containing protein
caused Hcrt-expressing neurons to die in the immediate
postnatal period. In fact, while this manuscript was under
review, Bewick et al. [27] reported that transgenic animals
carrying a polyglutamine-containing protein driven by the
Agrp promoter exhibit reduced adiposity and body weight,
similar to our observations. The later onset of neuronal cell
death induced by Tfam deﬁciency is likely explained by a
gradual depletion of mitochondrial gene products from
postmitotic cells, and therefore provides a model for
pathophysiologic changes related to the mitochondrial
theory of aging, in which progressive impairment of
mitochondrial function associated with oxidative damage is
thought to lead to a vicious circle that culminates in neuronal
apoptosis [35–37]. In a recent test of this model, Trifunovic et
al. [38] found that animals genetically engineered to
accumulate mitochondrial mutations developed several fea-
tures of premature aging. While not speciﬁcally tested by
Trifunovic et al. [38], our results predict that these animals
should exhibit a defective energy balance with an impairment
in compensatory hyperphagia.
From this perspective, the defective energy balance that
developed in our Pomc-ablation or double-ablation mice at 4
mo of age provides a useful model for age-related obesity. In
both rodents and humans, adiposity progressively increases
throughout most of adult life. Even in elderly individuals,
where total body weight (and subcutaneous fat) declines
toward the end of life, visceral adiposity continues to
increase, pointing to a fundamental age-related defect in
energy balance [1,3,5]. Elderly humans exhibit defects in both
the normal reduction in energy expenditure caused by
overfeeding [39], and the normal increase in perceived
hunger caused by underfeeding [40]. Defects in compensatory
hyperphagia similar to what we observed in our Pomc-
ablation or double-ablation mice have also been described in
studies of young (3-mo-old), middle-aged (12-mo-old), and
elderly (24-mo-old) rats from Matsumoto and colleagues
[6,41]. Notably, impaired energy homeostasis in the rat model
is associated with altered expression of Pomc [6] and Npy [41].
Thus, the neuronal-ablation mice we describe here represent
a model for premature dysfunction of hypothalamic circuits
implicated in the normal aging process.
Materials and Methods
Animal studies. Animals carrying the TfamloxP allele [16,17] were
kindly provided by N. Larsson (Karolinska Institute, Stockholm,
Sweden) on a mixed C57BL/6J and 129 background. Animals carrying
the R26R LacZ reporter allele were obtained from P. Soriano
(University of Washington, Seattle, Washington, United States), and
are maintained in our laboratory as homozygotes on a mixed
background that includes contributions from FVB/N, C57BL/6J, and
129 strains. The Tg.PomcCre and Tg.AgrpCre lines are maintained as
heterozygotes on the same mixed background; their construction and
characterization has been described previously [9]. We generated a
total of 128 animals for the Pomc-ablation mice (44 mutants, 62 Tfam
controls, and 22 Cre recombinase controls), 133 animals for the Agrp-
ablation mice (44 mutants, 54 Tfam controls, and 35 Cre recombinase
Figure 8. Compensatory Refeeding and Neuropeptide mRNA levels in
Pomc-Specific and Agrp-Specific Tfam Deficiency
(A–D) 24-h compensatory refeeding after a 48-h fast was measured as
described in Materials and Methods; data are shown either as (A and B)
the ratio of food consumed over 24 h (refeeding) to normal daily food
intake (averaged over 7 h prior to food deprivation), or as (C and D)
percentage of weight recovery after 24 h of refeeding. For the Pomc-
Tfam experiment (A and C), number of animals used was n¼ 23 (control)
and n¼13 (Pomc-Tfam mutant); for the Agrp-Tfam experiment (B and D),
number of animals used was n¼ 21 (control) and n¼ 15 (Agrp-Tfam).
(E) The same refeeding defects were observed in Pomc-Tfam mutants
after corticosterone replacement (control, n¼ 9; Pomc-Tfam mutant, n¼
6).
(F) Expression of Pomc, Agrp, and Npy in Pomc-Tfam mutants. Mice were
fasted for 48 h 10 d after implanting corticosterone pellets, and
expression of Pomc, Agrp, and Npy in the hypothalamus was measured
by semi-quantitative RT-PCR. Values are shown as relative levels
compared to free-fed controls. Numbers of animals used were n ¼ 5
(control fed); n¼ 5 (control fasted); n¼ 3 (mutant fed); and n¼ 3 (mutant
fasted).
*, p  0.05; **, p  0.01. Error bars¼ standard error of the mean.
DOI: 10.1371/journal.pbio.0030415.g008
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controls), and 42 double-ablation mice. To help control for differ-
ences in litter size and modiﬁer genes, results were analyzed by two-
way ANOVA in which sibship was included as a variable. Although the
genetic background was heterogeneous, there was less variation (both
environmental and genetic) within litters than between litters.
For feeding studies, animals were singly housed for 2 wk, then food
intake was measured for a consecutive 6–7 d; results are shown as an
average over 24 h. To measure compensatory refeeding, food was
removed 3 h before the onset of the dark cycle, mice were fasted for
48 h, then food was added back and food intake measured for the
next 24 h.
Metabolic monitoring was carried out with a system (AccuScan
Instruments, Columbus, Ohio, United States) located in the UC Davis
Department of Nutrition animal facility. The system consists of an O2
analyzer, CO2 analyzer, and PhysioScan analyzer, which monitors
vertical and horizontal movement via light beam interruption. A ﬂow
controller/channelyzer allows for ﬂow rate adjustments and sequen-
tial channeling of airﬂow from a reference line and the four animal
chambers through the CO2 and O2 analyzers. The ﬂow rate for these
experiments was 0.5 l/min. The dimensions of the plexiglas chambers
were 12 in 3 8 in 3 8 in. The Integra ME software includes O2 and
CO2 analyzer calibration, data collection, and analysis programs.
Reported and calculated values include O2 consumption, CO2
production, RQ, heat production (energy expenditure), total
ambulatory movement, and total rest time. Animals were acclimated
to the chambers for 20 h immediately prior to a 24-h data collection
period. Each animal received its normal diet and water while in the
chamber.
Body fat mass and lean mass were determined either by dual X-ray
absorptiometry (Pomc-ablation mice) or by MRI (Agrp-ablation
mice). In the former case, mice were anesthetized by intraperitoneal
injection of 2.5% avertin, and body composition was measured using
a PIXImus2 instrument. In the latter case, conscious animals were
analyzed with an MRI whole-body composition analyzer (Echo
Medical Systems, Houston, Texas, United States) at the Rodent
Energy Metabolism core at the University of Washington.
For studies involving corticosterone replacement, a 10-mg 21-d
release corticosterone pellet (Innovative Research of America,
Sarasota, Florida, United States) was implanted subcutaneously on
the lateral side of the neck of both ablation and control animals. This
dose of corticosterone is sufﬁcient for physiologic replacement and
has been shown to prevent adrenalectomy-induced anorexia [42].
Molecular biology. Measurements of mRNA levels were carried out
by quantitative RT-PCR on RNA extracted from dissected hypo-
thalamic tissue. Total RNA for each hypothalamus was quantiﬁed by
spectrophotometry after puriﬁcation using TRIzol reagent (Invitro-
gen, Carlsbad, California, United States) and an RNeasy mini kit
(Qiagen, Valencia, California, United States). 250 ng each total RNA
sample was reverse-transcribed, then PCR-ampliﬁed using a Light-
cycler (Roche Applied Science, Basel, Switzerland) and SYBR green to
mea su re r e l a t i v e cDNA le v e l s . Ag r p pr imer s we r e
TGCTACTGCCGCTTCTTCAA and CTTTGCCCAAACAACATCCA;
Npy primers were TAACAAGCGAATGGGGCTGT and ATCTGGC
CATGTCCTCTGCT; Pomc primers were AGGCCTGACACGTGGAA
GAT and AGGCACCAGCTCCACACAT; and Actb primers were
CTGCGTTTTACACCCTTTCTTTG and gccatgccaatgttgtctcttat. Efﬁ-
ciency for each primer set was estimated from standard curves made
with serial cDNA dilutions.
Xgal staining and immunohistochemistry for a-MSH or AGRP
was carried out as described previously [9]. For glial ﬁbrillary acidic
protein (GFAP) immunoﬂuorescence, a polyclonal anti-GFAP anti-
body (Dako, Glostrup, Denmark) was used at 1:1500 dilution
according to the protocol described in [9]. Goat–anti-rabbit
Alexa488 (Molecular Probes, Eugene, Oregon, United States; 1:200)
was used for secondary antibody detection. Sections were mounted
using Vectashield with DAPI (Vector Laboratories, Burlingame,
California, United States). Fluorescence images were captured using
a black-and-white digital camera (AxioCam MRm) attached to a
Zeiss Axioplan2 imaging system (Zeiss, Oberkochen, Germany), and
later pseudocolored to red (GFAP) and blue (DAPI) and super-
imposed.
For ﬂuorescence in situ hybridization to Agrp mRNA, brains were
frozen on dry ice, and 14-lm cryostat sections mounted on slides
using RNAse-free conditions. Labeling and hybridization were
carried out as described previously [43].
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